‹ All Posts
Chahat Aggrawal

13th Jan · SEBI-Registered Analyst

MedPlus Subsidiary Faces Drug License Suspensions

⚠️

MEDPLUS
informed that its subsidiary, Optival Health Solutions, has received six drug license suspension orders across select stores in Karnataka and Telangana, which may result in a potential revenue impact of approximately ₹6.98 lakh, as per the company’s latest disclosure.

#FundamentalViews#WatchOutFor
1,149 likes·61 comments